TITLE

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens

AUTHOR(S)
Hogg, Robert S.; Yip, Benita; Kully, Charlotte; Craib, Kevin J.P.; O'Shaughnessy, Michael V.; Schechter, Martin T.; Montaner, Julio S.G.
PUB. DATE
March 1999
SOURCE
CMAJ: Canadian Medical Association Journal;3/09/99, Vol. 160 Issue 5, p659
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Compares mortality and AIDS-free survival among HIV-infected patients in British Columbia who were treated with double- and triple-drug regimes. Methods; Results; Interpretation that treatment with a triple-drug antiretroviral regimen comprising 2 nucleoside analogue reverse transcriptase inhibitors (NRTI) plus a protease inhibitor or a non-NRTI have a lower risk of morbidity and death.
ACCESSION #
1662406

 

Related Articles

  • Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)—Associated Lipodystrophy Syndrome and Stavudine-Triphosphate Intracellular Levels in Patients with Stavudine-Based Antiretroviral Regimens. Domingo, Pere; Cabeza, Maria Carmen; Pruvost, Alain; Salazar, Juliana; del Mar Gutierrez, Maria; Mateo, Maria Gracia; Domingo, Joan C.; Fernandez, Irene; Villarroya, Francesc; Muñoz, Jessica; Vidal, Francesc; Baiget, Montserrat // Clinical Infectious Diseases;4/1/2010, Vol. 50 Issue 7, p1033 

    Background. The link between human immunodeficiency virus/highly active antiretroviral therapy (HAART)- associated lipodystrophy syndrome (HALS) and the use of thymidine analogues has been well established. However, to our knowledge, no relationship has been proven between intracellular levels...

  • Sequential vs. simultaneous antiretroviral HIV therapy. Huffman, Grace Brooke // American Family Physician;11/15/1998, Vol. 58 Issue 8, p1845 

    Focuses on how antiretroviral therapy that consists of a combination of two nucleoside analog reverse transcriptase inhibitors can suppress viral load in patients with human immunodefiency virus (HIV) infection. Methods used in the study; Results and discussion; Conclusion.

  • Introduction. Murphy, Robert L. // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS95 

    Discusses the challenges faced by clinicians in choosing an effective treatment regimen for patients with HIV infections. Decrease in the success rate and sustained treatment response to second-line therapies in clinics; Need to find effective treatment options that have favorable...

  • An HIV-Positive Patient Who Avoids Treatment. Legg, Jill J.; Goldschmidt, Ronald H. // American Family Physician;6/1/1999, Vol. 59 Issue 11, p3252 

    Comments on the case of an HIV-positive patient who avoids treatment. Reason for HIV-positive patients to avoid health care; Suggestions on how physicians can help HIV-positive patients go for treatment.

  • New combination.  // Formulary;Nov2012, Vol. 47 Issue 11, p384 

    The article reports on testing which the U.S. Food and Drug Administration conducted on the drug Truvada in 2012 in an effort to investigate its safety, efficacy and proper dosage levels. Approval for marketing which the administration gave to the drug after it completing its testing processes...

  • Reverse Transcriptase Inhibitors. Tripp, Ernest // Access;Jul2001, Vol. 15 Issue 6, p42 

    Explores the use of reverse transcriptase inhibitors in the management of HIV infections. Two ways on how reverse transcriptase inhibitors target HIV; Common reverse transcriptase medications; Drug combinations used in treating HIV infections.

  • New option for first-line treatment of HIV. Lucas, Beverly D. // Patient Care;3/15/1999, Vol. 33 Issue 5, p12 

    Reveals that physicians have an option to prescribe non-nucleoside reverse transcriptase inhibitor efavirenz as a first-line therapy for treating HIV infection. Effectiveness of the drug compared with a protease inhibitor; Recommended treatment regimen using efavirenz; Administration of...

  • Adolescents and HIV in Sub-Saharan Africa: A Timely Issue and Missed Opportunity. Coovadia, Hoosen; Mantell, Joanne E. // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, p852 

    The authors comment on issue related to the management of adult patients in Sub-Saharan, Africa who were infected with human immunodeficiency virus (HIV). They cite the context of the article by Ferrand and colleagues which focuses on the undiagnosed cases of HIV among adults living in the...

  • Management of the Adverse Effects of Antiretroviral Therapy and Medication Adherence. Max, Blake; Sherer, Renslow // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS96 

    Examines the therapeutic agents included in the highly active antiretroviral therapy (HAART) for the treatment of patients with HIV infections. Link between poor adherence and failure of antiretroviral therapy; Threat of short term-adverse effects to successful introduction and maintenance of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics